Skip to main content
Dishman Carbogen Amcis Limited (NSE:DCAL)
India flag India · Delayed Price · Currency is INR
164.23
-0.44 (-0.27%)
At close: Mar 6, 2026

Dishman Carbogen Amcis Revenue

Dishman Carbogen Amcis had revenue of 7.20B INR in the quarter ending December 31, 2025, with 5.49% growth. This brings the company's revenue in the last twelve months to 27.97B, up 5.55% year-over-year. In the fiscal year ending March 31, 2025, Dishman Carbogen Amcis had annual revenue of 27.12B with 3.66% growth.

Revenue (ttm)
27.97B
Revenue Growth
+5.55%
P/S Ratio
0.92
Revenue / Employee
25.29M
Employees
1,106
Market Cap
25.75B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202527.12B957.30M3.66%
Mar 31, 202426.16B2.03B8.41%
Mar 31, 202324.13B2.72B12.72%
Mar 31, 202221.41B2.29B11.96%
Mar 31, 202119.12B-1.32B-6.44%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Panacea Biotec 6.06B
Zota Health Care 4.73B
Supriya Lifescience 7.35B
Blue Jet Healthcare 10.53B
TAKE Solutions -70.53M
Concord Biotech 11.59B
OneSource Specialty Pharma 14.19B
Haleos Labs 3.48B
Revenue Rankings

Dishman Carbogen Amcis News

More News